Skip to main content
. 2018 Jun 7;23:31. doi: 10.1186/s40001-018-0328-7

Fig. 2.

Fig. 2

Expression changes of CCND1, ERBB2, KCNK5, KDM4B, and MYC after selective GPER agonist, G1 treatment. A significantly lower expression changes were observed compared to estrogen or estrogen–BSA treatments. Y-axis represents ddCT values, 0 line indicates control level. (Error bars represent standard deviation, asterisks indicate significant changes compared to control with a p value < 0.05). Numerical ddCT values are shown in Additional file 1: Table Sheet 5